LAS-R HUMAN ANTITHROMBIN III TEST— 510(k) K772328

Name: FDA 510(k) clearance K772328
Creator: U.S. Food and Drug Administration
Published: 1978-02-03

Substantially Equivalent

Hyland Therapeutic Div., Travenol Laboratories

FDA 510(k) clearance K772328 for LAS-R HUMAN ANTITHROMBIN III TEST, Substantially Equivalent on 1978-02-03. Applicant: Hyland Therapeutic Div., Travenol Laboratories. Device class: 2.

Clearance details

Applicant: Hyland Therapeutic Div., Travenol Laboratories
Product code: Code JBQ
Device class: Class 2
Regulation: 21 CFR 864.7060
Advisory panel: Hematology
Date received: 1977-12-21
Decision date: 1978-02-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JBQ

view all

K242952 — INNOVANCE Antithrombin2025-03-28
K081769 — INNOVANCE ANTITHROMBIN WITH MODELS OPFH03, OPFHO52009-05-28
K070301 — HEMOSIL ANTITHROMBIN2007-02-23
K062431 — HEMOSIL LIQUID ANTITHROMBIN2006-09-01
K043007 — BIOPHEN ANTITHROMBIN 2.5, REFERENCE # 221102; BIOPHEN ANTITHROMBIN 5, REFERENCE # 2211052005-11-07

More clearances from Hyland Therapeutic Div., Travenol Laboratories

view all

K820835 — ALUMINA SILICA-ACTIVATED PARTIAL THROM1982-04-26
K820192 — HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM1982-03-11
K812220 — NEPHELOMETRIC SOLID TURBIDITY STANDARD1981-08-18
K810078 — Q-PAK THERAPEUTIC DRUG MONIT. CONTROL S1981-02-02
K810077 — OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.1981-01-28

Data sourced from openFDA. This site is unofficial and independent of the FDA.